GILD ▼ -3.3% - Gilead Sciences, Inc. $GILD Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines Gilead Sciences fell 3.3% today despite the company's announcement of a new state-of-the-art research center aimed at advancing its pipeline of future medicines. The market's negative reaction suggests investors may have been disappointed by the lack of concrete clinical or financial details in the announcement, or saw the capital investment as a near-term headwind to profitability. 08-SEP-2026 01:00 PM ET